JOSHUA WARD: Open Payments
NPI 1982940516 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 29 payments from 7 companies in 2025. Trend: 2023 $80 · 2024 $13 · 2025 $717
Food & beverage: $546Education: $171
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $269 |
| Janssen Biotech, Inc. | 5 | $138 |
| Lilly USA, LLC | 6 | $105 |
| Eli Lilly and Company | 1 | $99 |
| GENZYME CORPORATION | 3 | $60 |
| ABBVIE INC. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Bimzelx, TREMFYA, TALTZ, DUPIXENT, SKYRIZI, Sotyktu.
Industry payments across AR — which companies pay providers there.
